Study Evaluating the Tolerance of Conjugate Meningococcal C Vaccine in Infants

Update Il y a 4 ans
Reference: NCT00314041

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Infant phase: To determine the safety of and production of antibodies by a group C meningococcal conjugate vaccine (MnCC), when given at 2, 3, and 4 months of age with routine vaccines. Booster phase: To compare the safety of and production of antibodies by MnCC with and without MMR and to compare the antibody response to that produced by a low dose of plain polysaccharide vaccine as a way of investigating immune memory


Inclusion criteria

  • Meningitis, Meningococcal

Links